Named as a key player in 99 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Biosimilars | Pharmaceuticals | $36.9 Bn | 24.9% |
| Digital Biomarkers | Digital Health | $4.4 Bn | 35.5% |
| Alzheimer Drugs | Pharmaceuticals | – | – |
Named as key players in the same markets as Biogen Inc (number of shared markets).
Amgen Inc.2 shared markets
Eli Lilly and Company2 shared markets
Novartis AG2 shared markets
AbbVie Inc.1 shared market
AliveCor Inc.1 shared market
Altoida Inc.1 shared market
Bayer AG1 shared market
Catalent1 shared market